Long-Standing Debate on Cisplatin- Versus Carboplatin-Based Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

Long-Standing Debate on Cisplatin- Versus Carboplatin-Based Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer

Published:2007-01 Issue:1 Volume:2 Page:96
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Hotta Katsuyuki,Matsuo Keitaro

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference5 articles.

1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials;Non-Small Cell Lung Cancer Collaborative Group;BMJ,1995

2. Third generation chemotherapy regimens (3GR) improve survival over second generation regimens (2GR) in stage IIIB/IV non-small cell lung cancer (NSCLC): a meta-analysis of the published literature (Abstract);Baggstrom;Proc Am Soc Clin Oncol,2002

3. Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin;Go;J Clin Oncol,1999

4. Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer;Hotta;J Clin Oncol,2004

5. CISCA (cisplatin vs. carboplatin) meta-analysis: an individual patient data meta-analysis comparing cisplatin versus carboplatin-based chemotherapy in first-line treatment of advanced non-small cell lung cancer (NSCLC) (Abstract);Ardizzoni;Proc Am Soc Clin Oncol,2006

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized study comparing mannitol with furosemide for the prevention of cisplatin‐induced renal toxicity in non‐small cell lung cancer: The OLCSG1406 trial;Asia-Pacific Journal of Clinical Oncology;2020-09-03

2. Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma;Journal for ImmunoTherapy of Cancer;2020-02

3. Nivolumab for the treatment of unresectable pleural mesothelioma;Expert Opinion on Biological Therapy;2019-12-16

4. Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan;International Journal of Clinical Oncology;2019-03-07

5. A phase II trial of EGFR-TKI readministration with afatinib in advanced non-small-cell lung cancer harboring a sensitive non-T790M EGFR mutation: Okayama Lung Cancer Study Group trial 1403;Cancer Chemotherapy and Pharmacology;2018-10-01